Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Prepaid Assets (2022 - 2025)

Taysha Gene Therapies (TSHA) has disclosed Prepaid Assets for 4 consecutive years, with $108000.0 as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 64.94% to $108000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $108000.0 through Dec 2025, down 64.94% year-over-year, with the annual reading at $108000.0 for FY2025, 64.94% down from the prior year.
  • Prepaid Assets hit $108000.0 in Q4 2025 for Taysha Gene Therapies, down from $456000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $3.7 million in Q1 2025 to a low of $108000.0 in Q4 2025.
  • Historically, Prepaid Assets has averaged $764000.0 across 4 years, with a median of $418000.0 in 2022.
  • Biggest YoY gain for Prepaid Assets was 2360.4% in 2025; the steepest drop was 79.96% in 2025.
  • Year by year, Prepaid Assets stood at $466000.0 in 2022, then tumbled by 37.34% to $292000.0 in 2023, then rose by 5.48% to $308000.0 in 2024, then crashed by 64.94% to $108000.0 in 2025.
  • Business Quant data shows Prepaid Assets for TSHA at $108000.0 in Q4 2025, $456000.0 in Q3 2025, and $657000.0 in Q2 2025.